Predictive value of electrocardiographic markers in children with dilated cardiomyopathy

Miao Wang1, Yi Xu1, Shuo Wang2

  • 1Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China.

Frontiers in Pediatrics
|September 9, 2022
PubMed

Insights

Electrocardiogram (ECG) markers offer valuable prognostic insights for children with dilated cardiomyopathy (DCM). This review summarizes ECG

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Biomedical Engineering

Background:

  • Dilated cardiomyopathy (DCM) involves ventricular dilation and impaired systolic function, leading to severe outcomes like arrhythmias, heart failure, and thromboembolism.
  • Electrocardiography (ECG) is a cost-effective, non-invasive tool for assessing cardiovascular disease prognosis.
  • While ECG studies in DCM are increasing, a comprehensive review of its prognostic value in pediatric DCM is lacking.

Purpose of the Study:

  • To review and summarize the prognostic value of electrocardiographic (ECG) markers in children diagnosed with dilated cardiomyopathy (DCM).
  • To consolidate current knowledge on how ECG findings can predict outcomes in pediatric DCM patients.

Main Methods:

  • Systematic literature review of studies investigating electrocardiographic markers in pediatric dilated cardiomyopathy.
  • Analysis of reported ECG parameters and their correlation with clinical outcomes, including arrhythmias, heart failure progression, and mortality.
  • Synthesis of findings to provide a comprehensive overview of ECG's prognostic utility.

Main Results:

  • Specific ECG findings, such as QRS duration, QT interval, and ST-T wave abnormalities, are associated with increased risk in pediatric DCM.
  • Certain ECG patterns correlate with the severity of systolic dysfunction and the likelihood of adverse events.
  • The review identifies key ECG markers that demonstrate significant prognostic value in this population.

Conclusions:

  • Electrocardiography is a crucial, non-invasive tool for risk stratification in children with dilated cardiomyopathy.
  • Identifying specific ECG markers can aid clinicians in predicting prognosis and guiding management strategies for pediatric DCM.
  • Further research into novel ECG-based biomarkers may enhance prognostic accuracy in pediatric DCM.

Related Concept Videos

Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
3.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
38
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
115
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
46
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
290